Format

Send to

Choose Destination
Eur Urol. 2013 Oct;64(4):e86-7. doi: 10.1016/j.eururo.2013.07.004. Epub 2013 Jul 12.

Re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007.: beta-blockers and prostate cancer survival--interpretation of competing risks models.

PMID:
23895794
DOI:
10.1016/j.eururo.2013.07.004
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center